The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.
about
Safety of dipeptidyl peptidase 4 inhibitors: a perspective reviewUse of metformin and vildagliptin for treatment of type 2 diabetes in the elderlyGastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis.Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study.Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitusEfficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agentPredictive clinical parameters and glycemic efficacy of vildagliptin treatment in korean subjects with type 2 diabetes.Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptinProfile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability.Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin.Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety.The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].DPP-4 inhibitors: pharmacological differences and their clinical implications.Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes.Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes.Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes.DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trials.Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized, open-label, prospective study (VISION)Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes
P2860
Q26863262-495B2C91-4177-48E9-AF0D-D4D10EBA826EQ33800171-D31DA19D-5069-4BC2-BA9A-29EFFFFD5587Q34915090-D70C2134-0BB8-413F-AE5D-2DCF77138524Q35808043-EC3D73BD-7730-4A13-AFC3-D1297828BD6BQ35997324-ABC154E5-FE07-4A83-B2C3-5609663D1E38Q36192977-A2AF3775-EF7A-4B68-8A39-30BD8475CBECQ36628919-C53F11B1-ABA0-4C86-A956-CBFC14A25A53Q36805122-7E0F9D53-5FC0-4A22-85C5-1A46A954E7DCQ36960161-B66D8948-7882-490D-A4A9-5FDD19AB2B73Q37471910-B95A0CA4-C94D-4744-93AC-410CFB1E4E92Q38126945-B0C839A4-1F86-4888-A71A-6E892F89F49AQ38205588-CE04C308-10FE-4AA4-85BF-6A697652B86EQ38244576-E348E3F0-99BE-49E2-9F6B-50010F43F9C0Q38335751-BFE20F16-ED80-4C99-B1A3-0B80E6AA852FQ38682317-E830D8B9-BFB8-43FE-8D2F-5445FB489875Q40054637-2B164C8C-4D69-4134-B79A-C01C319195A3Q40487459-36BF646A-6824-4527-A0FE-EBEBAC69C87BQ47188296-49FEAE45-DCDC-48A0-9576-5A9E7A7ADC57Q51281907-2DA27C98-33BA-4289-B35D-88F2194654E2Q57477167-732660FB-2B41-4753-86CE-030D31104C69
P2860
The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The efficacy and safety of vil ...... of randomized clinical trials.
@en
The efficacy and safety of vil ...... of randomized clinical trials.
@nl
type
label
The efficacy and safety of vil ...... of randomized clinical trials.
@en
The efficacy and safety of vil ...... of randomized clinical trials.
@nl
prefLabel
The efficacy and safety of vil ...... of randomized clinical trials.
@en
The efficacy and safety of vil ...... of randomized clinical trials.
@nl
P2093
P2860
P921
P1476
The efficacy and safety of vil ...... of randomized clinical trials.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2710.2011.01323.X
P577
2011-12-22T00:00:00Z